Study Stopped
COVID hindered enrollment
Treating Children With Obstructive Sleep Apnea After Surgery Failure
Residual Pediatric Obstructive Sleep Apnea: Closing the Treatment Gap
1 other identifier
observational
8
1 country
1
Brief Summary
The aim of this study is to evaluate the potential improvement of sleep quality in children who have residual obstructive sleep apnea, using either an orthodontic intervention or continuous positive airway pressure (CPAP), versus no treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2019
CompletedFirst Posted
Study publicly available on registry
January 30, 2019
CompletedStudy Start
First participant enrolled
December 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 8, 2023
CompletedJanuary 29, 2024
January 1, 2024
1.4 years
January 10, 2019
January 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Measure of change in OSA severity
Change from baseline Apnea-Hypopnea Index (OSA severity index) measurement by polysomnography at 12 months
baseline and 12 months
Change from baseline total score Pediatric Sleep Questionnaire (PSQ) at 12 months
PSQ consists of total 22 questions with choices of answer; Yes or No. Yes answer will be coded as 1 and No answer coded as 0. Sum of 22 questions will be compared.
baseline and 12 months
Secondary Outcomes (1)
Change from baseline body mass index (BMI) at 12 months
baseline and 12 months
Study Arms (3)
Continuous Positive Airway Pressure
This group consists of consenting patients and their parents who choose Continuous Positive Airway Pressure (CPAP). The CPAP is a type of therapy that applies mild air pressure to a person's upper airway to keep their airway open so that they can breathe normally while they sleep.
Orthodontic Intervention
This group consists of consenting patients and their parents who choose orthodontic intervention will be seen by participating orthodontists who will determine types of orthodontic intervention; mandibular advancement devices or rapid maxillary expansion devices, or Class III mid face advancement with skeletal anchored headgear. In this group, the patients will also receive a biometric shirt to use once every two weeks, to monitor their sleep during the study.
Control
This group consists of consenting patients and their parents who choose to remain untreated. In this group, the patients will also receive a biometric shirt to use once every two weeks, to monitor their sleep during the study.
Interventions
Mandibular advancement or Rapid maxillary expansion devices
Eligibility Criteria
Children from 6 to16 years old, from both sexes in Alberta, Canada, diagnosed with (a) residual OSA (post-T\&A) or (b) diagnosed with OSA but for whom T\&A is not a treatment option.
You may qualify if:
- Patients diagnosed with obstructive sleep apnea by polysomnography who presented with a failure in treatment with surgical removal of the tonsils and adenoid tissue --adenotonsillectomy (T\&A).
- Patients diagnosed with obstructive sleep apnea but for whom T\&A was not an option following assessment by Otolaryngology.
You may not qualify if:
- Autism spectrum
- Down syndrome
- Pulmonary hypertension
- Cystic fibrosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine and Dentistry
Edmonton, Alberta, T6G 2R7, Canada
Related Publications (1)
Fagundes NCF, Perez-Garcia A, Graf D, Flores-Mir C, Heo G. Orthodontic interventions as a management option for children with residual obstructive sleep apnea: a cohort study protocol. BMJ Open. 2022 Jun 15;12(6):e061651. doi: 10.1136/bmjopen-2022-061651.
PMID: 35705345DERIVED
Biospecimen
Urine, blood and saliva
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giseon Heo
Dentistry, University of Alberta
- STUDY CHAIR
Rochelle Young
Pediatric Respiratory Medicine, University of Alberta Hospital
- STUDY DIRECTOR
Paul Major
Dentistry, University of Alberta
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2019
First Posted
January 30, 2019
Study Start
December 3, 2021
Primary Completion
May 8, 2023
Study Completion
May 8, 2023
Last Updated
January 29, 2024
Record last verified: 2024-01